Biological analysis of herbal medicines used for the treatment of liver diseases

Biomedical Chromatography

Volumn 25, Issue 1, 2011, Pages 21-38

  Chien, Chao Feng ^a   Wu, Yu Tse ^a   Tsai, Tung Hu ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Bioanalysis; Complementary and alternative medicine; Herbal medicine; Traditional Chinese medicine

Indexed keywords

DISEASE CONTROL; FLAVONOIDS; MEDICAL APPLICATIONS;

BIOANALYSIS; BIOLOGICAL ANALYSIS; COMPLEMENTARY AND ALTERNATIVE MEDICINES; CONDITION; HEPATOPROTECTIVE; HERBAL MEDICINES; LIVER DISEASE; LIVER DISORDER; PROMISING THERAPY; TRADITIONAL CHINESE MEDICINE;

PLANT EXTRACTS;

1 NAPHTHOL; APIGENIN; ASTRAGALOSIDE IV; AURANTIIN; BAICALEIN; BAICALIN; CHLORAMPHENICOL; ERIODICTYOL; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; GOMISIN A; HERBACEOUS AGENT; INDOMETACIN; ISOSILIBININ; LIVER PROTECTIVE AGENT; NARINGENIN; NEOMINOPHAGEN C; SALVIANOLIC ACID B; SCHISANDRA CHINENSIS EXTRACT; SCHIZANDRIN; SCHIZANDRIN B; SILIBILININ A; SILIBILININ B; SILIBININ; SILICHRISTIN; SILIDIANIN; SILYMARIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID; XIAO CHAI HU TANG;

ANTIVIRAL ACTIVITY; ASTRAGALUS MEMBRANACEUS; BILIARY TRACT DISEASE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; ELECTROCHEMICAL DETECTION; GLYCYRRHIZA GLABRA; HEPATITIS; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; LIQUID LIQUID EXTRACTION; LIVER CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MASS SPECTROMETRY; MICRODIALYSIS; NONHUMAN; PRECIPITATION; PSEUDOHYPOALDOSTERONISM; REVIEW; SALVIA MILTIORRHIZA; SCHISANDRA CHINENSIS; SCHISANDRACEAE; SCUTELLARIA BAICALENSIS; SIDE EFFECT; SILYBUM MARIANUM; SODIUM RETENTION; SOLID PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WATER RETENTION;

ASTRAGALUS MEMBRANACEUS; GLYCYRRHIZA GLABRA; SALVIA MILTIORRHIZA; SCHISANDRA CHINENSIS; SCUTELLARIA BAICALENSIS; SILYBUM MARIANUM;

EID: 78650660164     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1568     Document Type: Review

References (103)

1. Akao T, Hayashi T, Kobashi K, Kanaoka M, Kato H, Kobayashi M, Takeda S and Oyama T. Intestinal bacterial hydrolysis is indispensable to absorption of 18 beta-glycyrrhetic acid after oral administration of glycyrrhizin in rats. The Journal of Pharmacy and Pharmacology 1994; 46: 135-137.
2. Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y and Kobashi K. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. The Journal of Pharmacy and Pharmacology 2000; 52:1563-1568.
3. Akao T, Sakashita Y, Hanada M, Goto H, Shimada Y and Terasawa K. Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2. Pharmaceutical Research 2004; 21: 2120-2126.
4. Akao T, Hanada M, Sakashita Y, Sato K, Morita M and Imanaka T. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2. The Journal of Pharmacy and Pharmacology 2007; 59: 87-93.
5. Albermann ME, Musshoff F, Hagemeier L and Madea B. Determination of glycyrrhetic acid after consumption of liquorice and application to a fatality. Forensic Science International 2010; 197: 35-39.
6. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M and Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997; 79: 1494-1500.
7. de Boer JG, Quiney B, Walter PB, Thomas C, Hodgson K, Murch SJ and Saxena PK. Protection against aflatoxin-B1-induced liver mutagenesis by Scutellaria baicalensis. Mutation Research 2005; 578: 15-22.
8. Chen YF, Jaw I, Shiao MS and Tsai TH. Determination and pharmacokinetic analysis of salvianolic acid B in rat blood and bile by microdialysis and liquid chromatography. Journal of Chromatography A 2005; 1088: 140-145.
9. Chien CF, Wu YT, Lee WC, Lin LC and Tsai TH. Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats. Chemico-Biological Interactions 2010; 184: 458-465.
10. Ching H, Hou YC, Hsiu SL, Tsai SY and Chao PD. Influence of honey on the gastrointestinal metabolism and disposition of glycyrrhizin and glycyrrhetic acid in rabbits. Biological and Pharmaceutical Bulletin 2002; 25: 87-91.
11. Citova I, Havlikova L, Urbanek L, Solichova D, Novakova L and Solich P. Comparison of a novel ultra-performance liquid chromatographic method for determination of retinol and alpha-tocopherol in human serum with conventional HPLC using monolithic and particulate columns. Analytical and Bioanalytical Chemistry 2007; 388: 675-681.
12. Cyong JC, Ki SM, Iijima K, Kobayashi T and Furuya M. Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine. The American Journal of Chinese Medicine 2000; 28: 351-360.
13. Di B, Feng N and Liu W. Pharmacokinetic comparisons of Shuang-Huang-Lian with the different combinations of its constitutional herbs. Journal of Ethnopharmacology 2006; 107: 401-405.
14. Ding L, Huang X, Yang J, Bian X, Zhang Z and Liu G. Determination of glycyrrhetic acid in human plasma by LC-ESI-MS. Journal of Pharmaceutical and Biomedical Analysis 2006; 40: 758-762.
15. Eddershaw PJ, Beresford AP and Bayliss MK. ADME/PK as part of a rational approach to drug discovery. Drug Discovery Today 2000; 5: 409-414.
16. Feng J, Xu W, Tao X, Wei H, Cai F, Jiang B and Chen W. Simultaneous determination of baicalin, baicalein, wogonin, berberine, palmatine and jatrorrhizine in rat plasma by liquid chromatography-tandem mass spectrometry and application in pharmacokinetic studies after oral administration of traditional Chinese medicinal preparations containing scutellaria-coptis herb couple. Journal of Pharmaceutical and Biomedical Analysis 2010; 53: 591-598.
17. Filburn CR, Kettenacker R and Griffin DW. Bioavailability of a silybin-phosphatidylcholine complex in dogs. Journal of Veterinary Pharmacology and Therapeutics 2007; 30: 132-138.
18. Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R and Glode LM. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Investigational New Drugs 2007; 25: 139-146.
19. Gao DY, Han LM, Zhang LH, Fang XL and Wang JX. Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs. Archives of Pharmacal Research 2009; 32: 773-779.
20. Gao QT, Chen XH and Bi KS. Comparative pharmacokinetic behavior of glycyrrhetic acid after oral administration of glycyrrhizic acid and Gancao-Fuzi-Tang. Biological and Pharmaceutical Bulletin 2004; 27: 226-228.
21. Gao R, Zheng Q, Gong T, Fu Y, Deng L and Zhang ZR. Gradient high-performance liquid chromatography for the simultaneous determination of chlorogenic acid and baicalin in plasma and its application in the study of pharmacokinetics in rats. Journal of Pharmaceutical and Biomedical Analysis 2007; 43: 335-340.
22. Gu Y, Wang G and Fawcett JP. Determination of Astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2004a; 801: 285-288.
23. Gu Y, Wang G, Pan G, Fawcett JP and Sun J. Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali. Basic and Clinical Pharmacology and Toxicology 2004b; 95: 295-298.
24. Guo X, Chen X, Li L, Shen Z, Wang X, Zheng P, Duan F, Ma Y and Bi K. LC-MS determination and pharmacokinetic study of six phenolic components in rat plasma after taking traditional Chinese medicinal-preparation: Guanxinning lyophilized powder for injection. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008a; 873: 51-58.
25. Guo ZJ, Zhang Y, Tang X, Li H and Sun QS. Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza Bunge after intravenous administration in rats. Biological and Pharmaceutical Bulletin 2008b; 31: 1469-1474.
26. Han DE, Gao ZD, Zhao D, Wang L, Li N, Li TT, Wu L and Chen XJ. Liquid chromatography mass spectrometry for the determination of salvianolic acid B, a natural compound from the herb Danshen in rat plasma and application to pharmacokinetic study. Biomedical Chromatography 2009; 23: 1073-1078.
27. He JX, Akao T, Nishino T and Tani T. The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang. Biological and Pharmaceutical Bulletin 2001; 24: 1395-1399.
28. Hoh CS, Boocock DJ, Marczylo TH, Brown VA, Cai H, Steward WP, Berry DP and Gescher AJ. Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites. Journal of Agricultural and Food Chemistry 2007; 55: 2532-2535.
29. Huang C, Wang G, Li H, Xie H, Sun J, Lv H and Lv T. Sensitive and selective liquid chromatography-electrospray ionisation-mass spectrometry analysis of astragaloside-IV in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 2006; 40: 788-793.
30. Huang H, Zhang Y, Yang R and Tang X. Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 874: 77-83.
31. Ip SP, Ma CY, Che CT and Ko KM. Methylenedioxy group as determinant of schisandrin in enhancing hepatic mitochondrial glutathione in carbon tetrachloride -intoxicated mice. Biochemical Pharmacology 1997; 54: 317-319.
32. Kageyama Y, Suzuki H and Saruta T. Renin-dependency of glycyrrhizin-induced pseudoaldosteronism. Endocrinologia Japonica 1991; 38: 103-108.
33. Kim WR, Brown RS Jr, Terrault NA and El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36: 227-242.
34. Kim YH, Jeong DW, Paek IB, Ji HY, Kim YC, Sohn DH and Lee HS. Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and wogonin in rat plasma. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 844: 261-267.
35. Koga K, Ohmachi K, Kawashima S, Takada K and Murakami M. Determination of 18alpha-glycyrrhizin and 18beta-glycyrrhizin in dog plasma by high-performance liquid chromatography. Journal of Chromatography B, Biomedical Sciences and Applications 2000; 738: 165-168.
36. Koga K, Tomoyama M, Ohyanagi K and Takada K. Pharmacokinetics of glycyrrhizin in normal and albumin-deficient rats. Biopharmaceutics and Drug Disposition 2008; 29: 373-381.
37. Kotani A, Kojima S, Hakamata H and Kusu F. HPLC with electrochemical detection to examine the pharmacokinetics of baicalin and baicalein in rat plasma after oral administration of a Kampo medicine. Analytical Biochemistry 2006; 350: 99-104.
38. Lai MY, Hsiu SL, Chen CC, Hou YC and Chao PD. Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans. Biological and Pharmaceutical Bulletin 2003a; 26: 79-83.
39. Lai MY, Hsiu SL, Tsai SY, Hou YC and Chao PD. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. The Journal of Pharmacy and Pharmacology 2003b; 55: 205-209.
40. Li W, Han J, Li Z, Li X, Zhou S and Liu C. Preparative chromatographic purification of diastereomers of silybin and their quantification in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 862: 51-57.
41. Lin SP, Tsai SY, Hou YC and Chao PD. Glycyrrhizin and licorice significantly affect the pharmacokinetics of methotrexate in rats. Journal of Agricultural and Food Chemistry 2009; 57: 1854-1859.
42. Lin ZJ, Qiu SX, Wufuer A and Shum L. Simultaneous determination of glycyrrhizin, a marker component in radix Glycyrrhizae, and its major metabolite glycyrrhetic acid in human plasma by LC-MS/MS. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005; 814: 201-207.
43. Liu H, Wei W, Sun WY and Li X. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. Journal of Ethnopharmacology 2009; 122: 502-508.
44. Liu JP, Manheimer E, Tsutani K and Gluud C. Medicinal herbs for hepatitis C virus infection. Cochrane Database of Systematic Reviews 2001a: CD003183.
45. Liu JP, McIntosh H and Lin H. Chinese medicinal herbs for chronic hepatitis B. Cochrane Database of Systematic Reviews 2001b: CD001940.
46. Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, Xu LM, Liu CH, Gu HT and Zhang ZQ. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology 2002; 8: 679-685.
47. Lu Y and Foo LY. Polyphenolics of Salvia-a review. Phytochemistry 2002; 59:117-140.
48. Lu Y, Li J and Wang G. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid. International Journal of Pharmaceutics 2008; 356: 274-281.
49. Ma Y and Wang T. A solid-phase extraction method for high-performance liquid chromatographic determination of salvianolic acid B in rabbit plasma: application to pharmacokinetic study. Biomedical Chromatography 2007; 21: 217-220.
50. Martinez-Ortega MV, Carcia-Parrilla MC and Troncoso AM. Comparison of different sample preparation treatments for the analysis of wine phenolic compounds in human plasma by reversed phase high-performance liquid chromatography. Analytica Chimica Acta 2004; 502: 49-55.
51. McDowall RD. Sample preparation for biomedical analysis. Journal of Chromatography 1989; 492: 3-58.
52. Miranda SR, Lee JK, Brouwer KL, Wen Z, Smith PC and Hawke RL. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2). Drug Metabolism and Disposition 2008; 36: 2219-2226.
53. Mizuhara Y, Takizawa Y, Ishihara K, Asano T, Kushida H, Morota T, Kase Y, Takeda S, Aburada M, Nomura M and Yokogawa K. The influence of the sennosides on absorption of glycyrrhetic acid in rats. Biological and Pharmaceutical Bulletin 2005; 28: 1897-1902.
54. Negi AS, Kumar JK, Luqman S, Shanker K, Gupta MM and Khanuja SP. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Medicinal Research Reviews 2008; 28: 746-772.
55. Plock N and Kloft C. Microdialysis-theoretical background and recent implementation in applied life-sciences. European Journal of Pharmaceutical Sciences 2005; 25: 1-24.
56. Pompei R, Flore O, Marccialis MA, Pani A and Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979; 281: 689-690.
57. Ran X, Liang Q, Luo G, Liu Q, Pan Y, Wang B and Pang C. Simultaneous determination of geniposide, baicalin, cholic acid and hyodeoxycholic acid in rat serum for the pharmacokinetic investigations by high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 842: 22-27.
58. Saller R, Meier R and Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 2001; 61: 2035-2063.
59. Sasaki K, Yonebayashi S, Yoshida M, Shimizu K, Aotsuka T and Takayama K. Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. International Journal of Pharmaceutics 2003; 265: 95-102.
60. Shibata N, Shimokawa T, Jiang Z, Jeong Y, Ohno T, Kimura G, Yoshikawa Y, Koga K, Murakami M and Takada K. Characteristics of intestinal absorption and disposition of glycyrrhizin in mice. Biopharmaceutics and Drug Disposition 2000; 21: 95-101.
61. Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. Journal of Gastroenterology and Hepatology 2000; 15 Suppl: D84-D90.
62. Stickel F and Schuppan D. Herbal medicine in the treatment of liver diseases. Digestive and Liver Disease 2007; 39: 293-304.
63. Takeda S, Ishthara K, Wakui Y, Amagaya S, Maruno M, Akao T and Kobashi K. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis. The Journal of Pharmacy and Pharmacology 1996; 48: 902-905.
64. Tang J, Shao B, Liu Y, Liu H, Ji H, Zhu D and Wu L. Highly sensitive determination of Schisandrin and Schisandrin B in plasma of rats after administration of Wurenchun (Fructus Schisandrae Chinensis Extracts) preparations by LC-ESI-MS/MS. Biomedical Chromatography 2010; 24: 675-681.
65. Tsai PL and Tsai TH. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study. Planta Medica 2004; 70: 1069-1074.
66. Tsai TH. Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P-glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysis. British Journal of Pharmacology 2001; 132: 1310-1316.
67. Tsai TH. Assaying protein unbound drugs using microdialysis techniques. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2003; 797: 161-173.
68. Tsai TH, Liao JF, Shum AY and Chen CF. Pharmacokinetics of glycyrrhizin after intravenous administration to rats. Journal of Pharmaceutical Sciences 1992; 81: 961-963.
69. Tsai TH, Liu SC, Tsai PL, Ho LK, Shum AY and Chen CF. The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study. British Journal of Pharmacology 2002; 137: 1314-1320.
70. Wakui Y, Yanagisawa E, Ishibashi E, Matsuzaki Y, Takeda S, Sasaki H, Aburada M and Oyama T. Determination of baicalin and baicalein in rat plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography 1992; 575: 131-136.
71. Wang BL, Hu JP, Tan W, Sheng L, Chen H and Li Y. Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis (Wuweizi) in rat plasma using liquid chromatography/mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 865: 114-120.
72. Wang R, Kong J, Wang D, Lien LL and Lien EJ. A survey of Chinese herbal ingredients with liver protection activities. Chinese Medicine 2007a; 2: 5.
73. Wang S, Li J, Huang H, Gao W, Zhuang C, Li B, Zhou P and Kong D. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali. Biological and Pharmaceutical Bulletin 2009a; 32: 132-135.
74. Wang X, Zhang ZR, Fu H, Liu J, Chen Q, Nie Y, Deng L and Gong T. Simultaneous determination and pharmacokinetic study of water-soluble and lipid-soluble components of danshen in rat plasma using HPLC-UV method. Biomedical Chromatography 2007b; 21: 1180-1185.
75. Wang Y, Yao Y, An R, You L and Wang X. Simultaneous determination of puerarin, daidzein, baicalin, wogonoside and liquiritin of GegenQinlian decoction in rat plasma by ultra-performance liquid chromatography-mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009b; 877: 1820-1826.
76. Wei H, Xu W, Cai F, Zhao G, Feng J, Sun L and Chen W. Simultaneous determination of five lignan constituents of Wuzhi capsule in rat plasma by LC-MS/MS: application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2010; 52: 741-746.
77. Wen XD, Qi LW, Li P, Bao KD, Yan XW, Yi L and Li CY. Simultaneous determination of calycosin-7-O-beta-d-glucoside, ononin, astragaloside IV, astragaloside I and ferulic acid in rat plasma after oral administration of Danggui Buxue Tang extract for their pharmacokinetic studies by liquid chromatography-mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008a; 865: 99-105.
78. Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW and Smith PC. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metabolism and Disposition 2008b; 36: 65-72.
79. Wu JW, Lin LC, Hung SC, Chi CW and Tsai TH. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. Journal of Pharmaceutical and Biomedical Analysis 2007; 45: 635-641.
80. Wu W, Wang Y and Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics 2006a; 63: 288-294.
81. Wu YT, Chen YF, Hsieh YJ, Jaw I, Shiao MS and Tsai TH. Bioavailability of salvianolic acid B in conscious and freely moving rats. International Journal of Pharmaceutics 2006b; 326: 25-31.
82. Xing J, Chen X and Zhong D. Absorption and enterohepatic circulation of baicalin in rats. Life Sciences 2005a; 78: 140-146.
83. Xing J, Chen X and Zhong D. Stability of baicalin in biological fluids in vitro. Journal of Pharmaceutical and Biomedical Analysis 2005b; 39: 593-600.
84. Xu M, Wang G, Xie H, Wang R, Wang W, Li X, Li H, Zhu D and Yue L. Determination of schizandrin in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005; 828: 55-61.
85. Xu M, Fu G, Qiao X, Wu WY, Guo H, Liu AH, Sun JH and Guo DA. HPLC method for comparative study on tissue distribution in rat after oral administration of salvianolic acid B and phenolic acids from Salvia miltiorrhiza. Biomedical chromatography 2007; 21: 1052-1063.
86. Yamamura Y, Kotaki H, Tanaka N, Aikawa T, Sawada Y and Iga T. The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats. Biopharmaceutics and Drug Disposition 1997; 18: 717-725.
87. Yan F, Zhang QY, Jiao L, Han T, Zhang H, Qin LP and Khalid R. Synergistic hepatoprotective effect of Schisandrae lignans with Astragalus polysaccharides on chronic liver injury in rats. Phytomedicine 2009; 16: 805-813.
88. Yan LX and Guo DA. Quantitation of astragaloside IV in rat plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005; 824: 244-248.
89. Yan-yu X, Yun-mei S, Zhi-peng C and Qi-neng P. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. International Journal of Pharmaceutics 2006; 319: 162-168.
90. Yanyu X, Yunmei S, Zhipeng C and Qineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. International Journal of Pharmaceutics 2006; 307: 77-82.
91. Ye JX, Wei W, Quan LH, Liu CY, Chang Q and Liao YH. An LC-MS/MS method for the simultaneous determination of chlorogenic acid, forsythiaside A and baicalin in rat plasma and its application to pharmacokinetic study of Shuang-huang-lian in rats. Journal of Pharmaceutical and Biomedical Analysis 2010; 52: 625-630.
92. Yi L, Jian-Ping G, Xu X and Lixin D. Simultaneous determination of baicalin, rhein and berberine in rat plasma by column-switching high-performance liquid chromatography. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 838: 50-55.
93. Yu S, Crawford E, Tice J, Musselman B and Wu JT. Bioanalysis without sample cleanup or chromatography: the evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes. Analytical Chemistry 2009; 81: 193-202.
94. Zeng MF, Pan LM, Zhu HX, Zhang QC and Guo LW. Comparative pharmacokinetics of baicalin in plasma after oral administration of Huang-Lian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats. Fitoterapia. 2010; doi:10.1016/j.fitote.2010.01.004.
95. Zhang J, Yu H, Sheng Y, Li L, Ye M and Guo D. HPLC determination and pharmacokinetic studies of salvianolic acid B in rat plasma after oral administration of Radix Salviae Miltiorrhizae extract. Biomedical Chromatography 2005a; 19: 15-18.
96. Zhang L, Lin G and Zuo Z. High-performance liquid chromatographic method for simultaneous determination of baicalein and baicalein 7-glucuronide in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 2004; 36: 637-641.
97. Zhang L, Xing D, Wang W, Wang R and Du L. Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract. Journal of Ethnopharmacology 2006; 103: 120-125.
98. Zhang W, Zhang C, Liu R, Li H, Zhang J, Mao C and Chen C. Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005b; 822: 170-177.
99. Zhao J and Agarwal R. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis 1999; 20: 2101-2108.
100. Zhao WJ, Wang BJ, Wei CM, Yuan GY, Bu FL and Guo RC. Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics. Journal of Clinical Pharmacy and Therapeutics 2008; 33: 289-294.
101. 2 induced liver injury. European Journal of Pharmacology 2006; 536: 192-199.
102. 4 intoxication model. Journal of Ethnopharmacology 1999; 67: 61-68.
103. Zou Q, Wei P, Li J, Ge ZX and Ouyang P. Simultaneous determination of 18alpha- and 18beta-glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics. Biomedical Chromatography 2009; 23: 54-62.